UC San Diego Perlman Medical Offices
La Jolla, California, United States
Medical clinic in San Diego, California
9350 Campus Point Dr, La Jolla, CA 92037
About UC San Diego Perlman Medical Offices
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Equillium
1
Galapagos NV
1
Xencor, Inc.
1
Clinical Trials at UC San Diego Perlman Medical Offices
During the past decade, UC San Diego Perlman Medical Offices conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
2010-01-01
2013-03-01
Completed
956
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
2015-11-09
2023-02-28
Active, not recruiting
398
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
2017-02-28
2025-05-01
Active, not recruiting
2,731
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
2019-05-29
2023-02-16
Completed
78
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
2019-10-01
2023-01-01
Recruiting
55
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
2020-11-10
2024-06-28
Active, not recruiting
24
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UC San Diego Perlman Medical Offices"
#1 collaborator was "Biocon Limited" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at UC San Diego Perlman Medical Offices
According to Clinical.Site data, the most researched conditions in "UC San Diego Perlman Medical Offices" are
"Arthritis, Rheumatoid" (2 trials), "Advanced Cancer" (1 trials), "Advanced or Metastatic Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Cervical Carcinoma" (1 trials). Many other conditions were trialed in "UC San Diego Perlman Medical Offices" in a lesser frequency.
Clinical Trials Intervention Types at UC San Diego Perlman Medical Offices
Most popular intervention types in "UC San Diego Perlman Medical Offices" are "Drug" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Axitinib" (1 trials), "Binimetinib" (1 trials), "CMP-001" (1 trials) and "CP-690,550" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UC San Diego Perlman Medical Offices
The vast majority of trials in "UC San Diego Perlman Medical Offices" are
8 trials for "All" genders.
Clinical Trials Status at UC San Diego Perlman Medical Offices
Currently, there are NaN active trials in "UC San Diego Perlman Medical Offices".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UC San Diego Perlman Medical Offices,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UC San Diego Perlman Medical Offices, 4 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".